Conclusions
VKH is a rare and potentially debilitating disorder in which severe complications can be avoided by early diagnosis and adequate treatment. It is imperative to keep up with advancing radiological and technological advancements to enable optimization of the rate of VKH diagnosis. Corticosteroids and immunosuppressants remain the mainstay of treatment for VKH. COVID-19 would be a potential immunological trigger of VKH in our patient if COVID-19 infection onset was prior to the 2-week history of VKH symptom onset or during VKH prodromal phase. Further investigation is necessary to establish whether this hypothesis is valid.
Keywords: VKH, COVID-19, comorbid, rare, infectious disease,